Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2007 June;142(3) > Giornale Italiano di Dermatologia e Venereologia 2007 June;142(3):277-83

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

A Journal on Dermatology and Sexually Transmitted Diseases


Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,311


eTOC

 

CASE REPORTS  


Giornale Italiano di Dermatologia e Venereologia 2007 June;142(3):277-83

Copyright © 2007 EDIZIONI MINERVA MEDICA

language: English

Atypical fibroxanthoma: the role of pre-existing neoplasia and acquired immunodeficiency. A series of 9 cases

Wollina U. 1, Güther S. 1, Köstler E. 1, Schönlebe J. 2, Ziemer M. 3, Koch A. 1, Schreiber G. 3, Haroske G. 2

1 Department of Dermatology and Allergology Dresden-Friedrichstadt Hospital Academic Teaching Hospital of the Technical University of Dresden, Dresden, Germany 2 Institute of Pathology “Georg Schmorl” Dresden-Friedrichstadt Hospital Academic Teaching Hospital of the Technical University of Dresden, Dresden, Germany 3 Department of Dermatology and Dermatological Allergology, Medical School Friedrich-Schiller-University of Jena, Jena, Germany


PDF  


Atypical fibroxanthoma (AFX) is a rare mesenchymal tumour of skin. We report on a series of 8 male patients and 1 female patient aged 68 to 90 years. All tumours were localized in the head and neck region. Six patients had a cancer history, 1 had a renal transplant and 1 suffered from systemic sarcoidosis. Medical history was positive for radiotherapy or chemotherapy in 4 patients. Histology showed a mostly spindle shaped dermal and subcutaneous tumour growth intermingled with multinucleated giant cells. The phenotype of tumour cells was vimentin positive but S100 and keratin negative. Some tumours showed a focal expression of CD68. Complete surgical excision controlled microhistographically (“Mohs like”) was possible in all cases followed by mesh-graft transplantation in 3 patients. Six patients showed a complete remission but 1 had a local relapse followed by regional metastasis was seen in 1 patient. Undefined lymph node enlargements of the chest were seen in another one. It is suggested that a medical history of neoplasia and/or immunosuppression/immunodeficiency might be a risk factor for AFX in elderly people. We recommend a follow-up of 5 years after diagnosis of AFX in analogy to non melanoma skin cancer since the tumour can show local relapse or develop metastatic spread.

top of page

Publication History

Cite this article as

Corresponding author e-mail